Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02347930

Enrollment

196

Registered

2015-01-28

Start date

2014-04-30

Completion date

2017-12-30

Last updated

2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

acute kidney injury, ultrasound technology

Brief summary

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis gold standard. Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Interventions

OTHERkidney ultrasound

kidney ultrasound

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Subjects must satisfy the following criteria to be enrolled in the study: 1. Clinical diagnosis of acute or chronic kidney injury 2. Male or female, aged 18-80 years old 3. signed informed consent 4. Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Exclusion criteria

* Potential subjects who meet any of the following criteria will be excluded from participating in the study: 1. Refuse to sign informed consent 2. allergy to micro bubble hexafluoride drug 3. Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections 4. Patients with asthma, chronic bronchitis 5. Patients with pregnancy 6. Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe 7. Patients beening diagnosed with End-stage kidney disease.

Design outcomes

Primary

Measure	Time frame
compare the results of kidney ultrasound with biomarkers of acute kidney injury	up to 24 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026